Primary |
Contraception |
46.7% |
Drug Use For Unknown Indication |
9.3% |
Drug Exposure During Pregnancy |
8.0% |
Osteoarthritis |
5.3% |
Menstruation Irregular |
4.0% |
Product Used For Unknown Indication |
4.0% |
Hypertension |
2.7% |
Oral Contraception |
2.7% |
Rash |
2.7% |
Anaemia |
1.3% |
Depression |
1.3% |
Diabetes Mellitus |
1.3% |
Dysmenorrhoea |
1.3% |
Haemorrhage |
1.3% |
Hypothyroidism |
1.3% |
Menopause |
1.3% |
Menorrhagia |
1.3% |
Menstrual Disorder |
1.3% |
Muscle Spasms |
1.3% |
Ovarian Cyst |
1.3% |
|
Premature Baby |
13.2% |
Weight Increased |
10.5% |
Off Label Use |
7.9% |
Vomiting |
7.9% |
Keratopathy |
5.3% |
Metrorrhagia |
5.3% |
Pregnancy On Oral Contraceptive |
5.3% |
Premature Labour |
5.3% |
Pulmonary Embolism |
5.3% |
Thrombosis |
5.3% |
Vision Blurred |
5.3% |
Abortion Spontaneous |
2.6% |
Anxiety |
2.6% |
Breast Swelling |
2.6% |
Cerebrovascular Accident |
2.6% |
Death |
2.6% |
Drug Exposure During Pregnancy |
2.6% |
Injury |
2.6% |
Menstrual Disorder |
2.6% |
Multiple Sclerosis |
2.6% |
|
Secondary |
Contraception |
50.0% |
Oral Contraception |
12.5% |
Product Used For Unknown Indication |
12.5% |
Menstruation Irregular |
6.3% |
Rash |
6.3% |
Haemorrhage |
3.1% |
Muscle Spasms |
3.1% |
Ovarian Cyst |
3.1% |
Post Coital Contraception |
3.1% |
|
Off Label Use |
21.4% |
Tachycardia |
21.4% |
Vomiting |
21.4% |
Abdominal Pain Upper |
7.1% |
Breast Swelling |
7.1% |
Liver Disorder |
7.1% |
Liver Function Test Abnormal |
7.1% |
Rash Generalised |
7.1% |
|
Concomitant |
Contraception |
18.0% |
Drug Use For Unknown Indication |
12.1% |
Product Used For Unknown Indication |
11.1% |
Asthma |
8.5% |
Oral Contraception |
7.7% |
Depression |
6.7% |
Acne |
4.9% |
Mastocytosis |
3.6% |
Hypersensitivity |
3.3% |
Crohn's Disease |
2.6% |
Pain |
2.6% |
Post Coital Contraception |
2.6% |
Premenstrual Syndrome |
2.6% |
Dysmenorrhoea |
2.3% |
Migraine |
2.3% |
Anxiety |
2.1% |
Menorrhagia |
2.1% |
Rheumatoid Arthritis |
2.1% |
Anaphylactic Reaction |
1.5% |
Cyst Removal |
1.5% |
|
Pain |
14.9% |
Vomiting |
13.5% |
Weight Increased |
9.5% |
Nausea |
6.8% |
Deafness |
5.4% |
Drug Exposure During Pregnancy |
4.1% |
Menstruation Irregular |
4.1% |
Pelvic Pain |
4.1% |
Pregnancy |
4.1% |
Pulmonary Embolism |
4.1% |
Renal Colic |
4.1% |
Thrombosis |
4.1% |
Cerebrovascular Accident |
2.7% |
Cholelithiasis |
2.7% |
Drug Effect Decreased |
2.7% |
Gallbladder Cholesterolosis |
2.7% |
Myositis |
2.7% |
Nervousness |
2.7% |
Oedema Peripheral |
2.7% |
Pelvic Abscess |
2.7% |
|